STARGEN

USPTO USPTO 2007 ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke STARGEN wurde als Wortmarke am 10.08.2007 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE".

Markendetails Letztes Update: 07. Juni 2018

Markenform Wortmarke
Aktenzeichen 77252613
Anmeldedatum 10. August 2007

Markeninhaber

Medawar Centre, Robert Robinson Avenue
OX44GA Oxford
GB

Markenvertreter

Waren und Dienstleistungen

5 Gene therapy and prophylaxis products, namely, proteins, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic and angiogenic molecules, all for the treatment of degenerative diseases of the eyes, including Stargardt disease and other degenerative diseases of the eyes; pharmaceutical preparations for treatment of degenerative diseases of the eyes, including Stargardt disease and other degenerative diseases of the eye; retroviral vector and retroviral vector manufacturing preparations, namely, pharmaceutical and biochemical preparations for the treatment of degenerative diseases of the eyes, including Stargardt disease and other degenerative retinal diseases; gene based pharmaceutical preparations for the treatment of degenerative diseases of the eyes
42 Scientific and medical research and development in respect of diseases of the eye; genetic engineering services; biotechnology services, relating to gene therapy products, namely, development of new technology for others in the field of biotechnology and medical research, namely, development of new technologies for others for diagnosis and treatment of diseases of the eyes
45 Licensing of intellectual property in respect of gene therapy products
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1377252613